Literature DB >> 25868057

Microclimate impact of prophylactic dressings using in vitro body analog method.

Evan Call1, Justin Pedersen2, Brian Bill3, Craig Oberg3, Martin Ferguson-Pell4.   

Abstract

UNLABELLED: Wound dressings have been successfully explored for use in prevention of pressure ulcers in individuals who are at clinical high-risk for developing ulcers.
METHODS: In this study, application of a recently described body analog test fixture and method is used to evaluate performance features of 8 clinically available dressings for prophylaxis. Documenting dressing performance is essential to defining the proper use and limits to application of dressings for ulcer prevention. These in vitro studies were undertaken to characterize the impact on the microclimate generated by the application of a dressing to the surface of the skin.
RESULTS: The measurement of moisture trapped next to the skin, moisture escaped from the dressing, and heat trapped by the dressing show that some dressings are more suited for skin protection.
CONCLUSION: It is evident that an optimal performance band for microclimate management exists in the application of dressings for prophylaxis, and that dressings should be evaluated for proper performance prior to implementation in a pressure ulcer prevention program. .

Entities:  

Year:  2013        PMID: 25868057

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  2 in total

1.  Enhancing pressure ulcer prevention using wound dressings: what are the modes of action?

Authors:  Evan Call; Justin Pedersen; Brian Bill; Joyce Black; Paulo Alves; C Tod Brindle; Carol Dealey; Nick Santamaria; Michael Clark
Journal:  Int Wound J       Date:  2013-07-30       Impact factor: 3.315

Review 2.  Systematic review of the use of prophylactic dressings in the prevention of pressure ulcers.

Authors:  Michael Clark; Joyce Black; Paulo Alves; Ct Brindle; Evan Call; Carol Dealey; Nick Santamaria
Journal:  Int Wound J       Date:  2014-01-29       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.